http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
TG Therapeutics (TGTX) Announces Publication of Final Results from Phase 3 GENUINE Trial Evaluating Ublituximab Plus Ibrutinib in Patients with R/R High-Risk Chronic Lymphocytic Leukemia in The Lancet
-
TG Therapeutics Announces Publication of Final Results from the Phase 3 GENUINE Trial Evaluating Ublituximab Plus Ibrutinib in Patients with Relapsed/Refractory High-Risk Chronic Lymphocytic Leukemia
-
TG Therapeutics (TGTX) Announces FDA Accelerated Approval of UKONIQ
-
TG Therapeutics Announces FDA Accelerated Approval of UKONIQ™ (umbralisib)
-
Ligand Partner TG Therapeutics Presents Positive Pre-clinical Data on IRAK4 Compounds at the American Association for Cancer Research (AACR) Annual Meeting
